Home Craig Hallum Reiterates Buy Rating for Ligand Pharmaceuticals
 

Keywords :   


Craig Hallum Reiterates Buy Rating for Ligand Pharmaceuticals

2015-05-24 10:58:48| Biotech - Topix.net

's stock had its "buy" rating restated by investment analysts at Craig Hallum in a note issued to investors on Saturday. They currently have a $105.00 target price on the biotechnology company's stock, up from their previous target price of $90.00.

Tags: buy rating craig pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11AKB48 1st
14.11kindle 10
14.11
14.11YAMAHA PORTATONE PSR-340
14.112003 112
14.11 14533.5
14.11caligari 17
14.11 amnjx 27circus
More »